INS and metabolic syndrome: On the epigenetic level, an early study designated SOCS3, a gene involved in leptin and insulin signaling, and found that its methylation reduced the risk of MetS and its component, whose effect was also confirmed in later studies for protection against adverse cardiometabolic effects of obesity (Ali et al., 2016).